Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Seamlessly bridge your LNP discovery journey from RUO to bulk GLP-tox and GMP excipient-grade material.
Explore CGMP Lipid ServicesOC2-K3-E10 is an ionizable cationic lipid.1 It has been used in the formation of lipid nanoparticles (LNPs) for the delivery of long intergenic noncoding RNA (lncRNA) in mice and for the delivery of CRISPR complementary single-guide RNA (sgRNA) and Cas9 mRNA for genome editing in transgenic mice.2,1 LNPs containing OC2-K3-E10 and encapsulating either gastric adenocarcinoma predictive lncRNA (GAPLINC) or diabetes-regulated anti-inflammatory RNA (DRAIR) lncRNA reduce LPS-induced increases in serum IL-1β or TNF-α and IL-6 levels, respectively, in mice.2 OC2-K3-E10-containing LNPs encapsulating macrophage inflammation-suppressing transcript lncRNA (MIST) modified with pseudouridine (ψ), but not with N1-methylpseudouridine (m1ψ) or 5-methylcytosine (m5C), reduce LPS-induced increases in TNF-α levels in mice.
WARNING This product is not for human or veterinary use.
1. Multi-
2. Human and mouse long noncoding RNAs reengineered for exogenous delivery reduce LPS-